We are pleased to announce that Prof. Dr. Omar Cauli has been appointed as the Editor-in-Chief of Diseases (ISSN: 2079-9721).

Prof. Dr. Omar Cauli is a professor of pathophysiology at the Department of Nursing at the University of Valencia, Valencia, Spain. He graduated with a degree in pharmacy at the University of Cagliari (Italy) and a degree in medicine at the University of Valencia (Spain). He also has a Ph.D. in neuroscience with a specialization in pharmacology from the University of Valencia. For the past 25 years, Prof. Dr. Omar Cauli has specialized in the fields of neuro-psychiatric diseases and geriatric medicine. He joined the journal Diseases as the Section Editor-in-Chief for the Section “Neuro-psychiatric Disorders” in 2018. He also serves as a Guest Editor and Topic Editor and has led several Special Issues and Topic Collections for Diseases and other MDPI journals.

Prof. Dr. Omar Cauli is also the Chair of the 1st International Online Conference on Diseases, which will be held from 9 to 11 September 2025. For more information, you may refer to https://sciforum.net/event/IOCD2025?section=#instructions.

The following is a short Q&A with Prof. Dr. Omar Cauli, who shared his vision for the journal and his views on the research area:

1. What about the journal appealed to you and made you want to take on the role as its Editor-in-Chief?

Diseases provides an invaluable platform for high-quality innovative scholarship dealing with diseases, ranging from the molecular to the clinical points of view, thanks to the efforts of the previous Editor-in-Chief, Prof. Dr. Maurizio Battino. I have had a pleasant experience with the journal as the Section Editor-in-Chief for the Section “Neuro-psychiatric Disorders” since 2018, during which I have edited five Special Issues for the journal while serving on the Editorial Board of Diseases. I have been very grateful for these opportunities.

2. What is your vision for the journal Diseases?

While keeping up the high standards for scholarship that Diseases has established, I do hope to expand the journal’s scope in certain fields. I have added two new Subject Sections “Endocrine and Metabolic Diseases” and “Autoimmune/Inflammatory Diseases”, with the goal of including a variety of approaches derived from the study of these fields. I see the need to bring in several Associate Editors to support this expansion.

3. What does the future of this field of research look like?

Due to the continuous progress of science and medicine, it is evident that the field of diseases, from the molecular to the clinical perspectives, will continue to grow and evolve.  The scientific evidence so far suggests that from the clinical point of view, inter- and multidisciplinary approaches are crucial for disease management. In addition, a personalized approach to individuals and patients with certain types of diseases will be the future of the treatment and care of people with health problems. I would like the journal to present papers that are based on the latest advances which are rooted in new molecular discoveries regarding each disease and the multidisciplinary and interdisciplinary approaches to disease management, especially in the context of chronicity.

4. What do you think of the development of open access research in the publishing field?

Open access publication of scientific results creates a level playing field for all researchers worldwide, regardless of their location, status, or affiliation. It can only be a good thing. It removes the limitations and biases of intellectual development from parts of academia and allows everyone to keep up with scientific advances, regardless of their ability to pay to learn. It may be a difficult balance from the publishers’ point of view, but to me, it is the right direction.

We warmly welcome Prof. Dr. Omar Cauli as our Editor-in-Chief and look forward to his valuable input for the continued success of Diseases. Further details regarding the journal and the latest news can be found at the following link: https://www.mdpi.com/journal/diseases.